BCR and pachyonychia congenita: Accurate staging of disease burden following BCR may permit patient specific management in this setting, including optimal treatment of oligometastatic disease and potential long‐term BCR‐free survival, as has been previously reported following extended pelvic lymph node (LN) clearance in the setting of PET detected pelvic LN recurrent PC.9